-
1
-
-
33747331935
-
Obesity, proteinuria and progression of renal failure
-
Praga M, Morales E. Obesity, proteinuria and progression of renal failure. Curr Opin Nephrol Hypertens 2006; 15: 481-486.
-
(2006)
Curr Opin Nephrol Hypertens
, vol.15
, pp. 481-486
-
-
Praga, M.1
Morales, E.2
-
2
-
-
0344465427
-
After all those fat years: Renal consequences of obesity
-
Wolf G. After all those fat years: renal consequences of obesity. Nephrol Dial Transplant 2003; 18: 2471-2474.
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 2471-2474
-
-
Wolf, G.1
-
3
-
-
0347992782
-
Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects
-
Bosma RJ, van der Heide JJ, Oosterop EJ et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-265.
-
(2004)
Kidney Int
, vol.65
, pp. 259-265
-
-
Bosma, R.J.1
van der Heide, J.J.2
Oosterop, E.J.3
-
4
-
-
33845271259
-
Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: Long-term follow-up
-
Navarro-Diaz M, Serra A, Romero R et al. Effect of drastic weight loss after bariatric surgery on renal parameters in extremely obese patients: long-term follow-up. J Am Soc Nephrol 2006; 17(Suppl 3): S213-S217.
-
(2006)
J Am Soc Nephrol
, vol.17
, Issue.SUPPL. 3
-
-
Navarro-Diaz, M.1
Serra, A.2
Romero, R.3
-
5
-
-
0022148271
-
Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies
-
O'Donnell MP, Kasiske BL, Cleary MP, Keane WF. Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J Lab Clin Med 1985; 106: 605-610.
-
(1985)
J Lab Clin Med
, vol.106
, pp. 605-610
-
-
O'Donnell, M.P.1
Kasiske, B.L.2
Cleary, M.P.3
Keane, W.F.4
-
6
-
-
0345599866
-
Peroxisome proliferator-activated receptor γ agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity
-
Baylis C, Atzpodien EA, Freshour G, Engels K. Peroxisome proliferator-activated receptor γ agonist provides superior renal protection versus angiotensin-converting enzyme inhibition in a rat model of type 2 diabetes with obesity. J Pharmacol Exp Ther 2003; 307: 854-860.
-
(2003)
J Pharmacol Exp Ther
, vol.307
, pp. 854-860
-
-
Baylis, C.1
Atzpodien, E.A.2
Freshour, G.3
Engels, K.4
-
7
-
-
1942486745
-
Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function
-
Eikelis N, Lambert G, Wiesner G et al. Extra-adipocyte leptin release in human obesity and its relation to sympathoadrenal function. Am J Physiol Endocrinol Metab 2004; 286: E744-E752.
-
(2004)
Am J Physiol Endocrinol Metab
, vol.286
-
-
Eikelis, N.1
Lambert, G.2
Wiesner, G.3
-
8
-
-
34547486885
-
Hypertension and impaired renal function accompany juvenile obesity: The effect of prenatal diet
-
Williams PJ, Kurlak LO, Perkins AC et al. Hypertension and impaired renal function accompany juvenile obesity: the effect of prenatal diet. Kidney Int 2007; 72: 279-289.
-
(2007)
Kidney Int
, vol.72
, pp. 279-289
-
-
Williams, P.J.1
Kurlak, L.O.2
Perkins, A.C.3
-
9
-
-
15544369982
-
Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming
-
McMillen IC, Robinson JS. Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571-633.
-
(2005)
Physiol Rev
, vol.85
, pp. 571-633
-
-
McMillen, I.C.1
Robinson, J.S.2
-
10
-
-
0037340168
-
The kidney, hypertension, and obesity
-
Hall JE. The kidney, hypertension, and obesity. Hypertension 2003; 41: 625-633.
-
(2003)
Hypertension
, vol.41
, pp. 625-633
-
-
Hall, J.E.1
|